SC
ELV icon

Sapient Capital’s Elevance Health ELV Stock Holding History

Sapient Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$757K Sell
1,958
-654
-25% -$243K 0.01% 223
2026
Q1 		$765K Buy
2,612
+31
+1% +$10.2K 0.01% 224
2025
Q4 		$900K Sell
2,581
-928
-26% -$314K 0.01% 211
2025
Q3 		$1.12M Hold
3,509
– – 0.02% 179
2025
Q2 		$1.36M Sell
3,509
-71
-2% -$28.6K 0.02% 160
2025
Q1 		$1.56M Sell
3,580
-41
-1% -$16.5K 0.03% 164
2024
Q4 		$1.34M Sell
3,621
-631
-15% -$264K 0.03% 166
2024
Q3 		$2.21M Sell
4,252
-132
-3% -$70.5K 0.04% 136
2024
Q2 		$2.38M Buy
4,384
+16
+0.4% +$8.46K 0.05% 122
2024
Q1 		$2.26M Sell
4,368
-700
-14% -$348K 0.05% 129
2023
Q4 		$2.39M Buy
+5,068
New +$2.34M 0.06% 123

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sapient Capital's ELV Position: Q2 2026 in Review

Sapient Capital reduced its Elevance Health (ELV) stake by 25% in Q2 2026, selling an estimated $243K and leaving 1,958 shares worth $757K. The position accounts for 0.01% of the portfolio, ranked #223.

Sapient Capital first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.39M in Q4 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sapient Capital held 1,958 shares of Elevance Health worth $757K as of Q2 2026.
  • Sapient Capital sold 654 Elevance Health shares in Q2 2026, an estimated $243K.
  • Elevance Health made up 0.01% of Sapient Capital's portfolio in Q2 2026, its #223 holding.
  • Sapient Capital first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Elevance Health position peaked at $2.39M in Q4 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.